Polycystic Ovary Syndrome and the Metabolic Syndrome

Polycystic Ovary Syndrome and the Metabolic Syndrome Julie L. Sharpless , MD Abstract In Brief Many patients with polycystic ovary syndrome (PCOS) also have features of the metabolic syndrome, including insulin resistance, obesity, and dyslipidemia, suggesting an increased risk for cardiovascular di...

Full description

Saved in:
Bibliographic Details
Published inClinical diabetes Vol. 21; no. 4; pp. 154 - 161
Main Author Sharpless, Julie L.
Format Journal Article
LanguageEnglish
Published Alexandria American Diabetes Association 01.10.2003
Subjects
Cardiovascular disease
Diabetes
Drug therapy
Medical treatment
Online AccessGet full text

Cover

More Information
Summary:Polycystic Ovary Syndrome and the Metabolic Syndrome Julie L. Sharpless , MD Abstract In Brief Many patients with polycystic ovary syndrome (PCOS) also have features of the metabolic syndrome, including insulin resistance, obesity, and dyslipidemia, suggesting an increased risk for cardiovascular disease. Increased awareness of this overlap advocates therapies that improve insulin resistance and often ameliorate PCOS symptoms. Footnotes Julie L. Sharpless, MD, is an assistant professor of medicine at the University of North Carolina School of Medicine in Chapel Hill, NC. American Diabetes Association
ISSN:0891-8929
1945-4953
DOI:10.2337/diaclin.21.4.154